海外の治験の状況「前立腺癌」での検索結果
1909件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A study to assess the usefulness of fluciclovine (18F) PET/CT in patients with rising PSA after treatment of prostate cancer
- Prostate cancer with biochemical recurrence after radical treatment MedDRA version: 20.0 Level: PT Classification code 10036911 Term: Prostate cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
- United Kingdom
- 2015-04-15
Not recruiting
- FFOCT for the Diagnosis of Prostate Cancer
- Patients With PSA Level 4.0 ng/mL;Patients With PSA Level 4.0 ng/mL;Patients With PSA Level 4.0 ng/mL
- France
- 2015-03-16
Not recruiting
- Vaccination in Prostate Cancer (VANCE)
- Prostate Cancer
- United Kingdom
- 2015-03-10
Not recruiting
- BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)
- Prostatic Neoplasms, Castration-Resistant
- Germany, Hong Kong, Korea, Republic of, Netherlands, Singapore, Spain, Taiwan, United Kingdom, United States
- 2014-07-29
Authorised
- An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Metastatic castration-resistant prostate cancer (mCRPC) MedDRA version: 20.0 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Russian Federation, South Africa, Spain, United Kingdom, United States
- 2014-05-13
Recruiting
- A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer
- Metastatic Castration Resistant Prostate Cancer
- Switzerland, United Kingdom, United States
- 2016-12-01
Recruiting
- A Trial Assessing Post-Operative Use of ProSpare, a Rectal Obturator in Prostate Cancer Radiotherapy
- Cancer
- United Kingdom
- 2016-11-25
Recruiting
- Quality of Life and Sexuality in Patients With Prostate Cancer
- Quality of Life
- Italy
- 2016-11-09
Authorised
- Cabazitaxel in metastatic prostate cancer patients with AR-V7 positive CTCs
- metastatic castration-resistant prostate cancer;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
- Netherlands
- 2016-11-08
Authorised
- Study investigating intravenously administrated Oncocort in patients with metastatic prostate cancer
- Castration resistant prostate cancer with bone metastases. MedDRA version: 19.1 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Netherlands
- 2016-11-08